Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.073 AUD | -1.35% | -2.67% | +5.80% |
04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
1st Jan change | Capi. | |
---|---|---|
+5.80% | 50.12M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Limited Announces Transition of Peter Griffiths as CEO